GeneDx Holdings paid its 3 named executives $21.8M in total in FY2025 (Dec). CEO Katherine Stueland was paid $13.5M of that.
Pay$100 in the stock at the end of FY21 → $88
Pay of each named executive
Katherine StuelandChief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed |
4 years
Kevin FeeleyChief Financial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed |
4 years
Bryan DechairoChief Operating Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed |
3 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 9 peers with pay on file was $9.1M. The CEO of GeneDx Holdings was paid $13.5M, 49% above the median.
- 1Natera
- 2Twist Bioscience
- 3GeneDx HoldingsThis company
- 4Ultragenyx Pharmaceutical
- 5Mirum Pharmaceuticals
- 6Adaptive Biotechnologies
- 7Veracyte
- 8CareDx
- 910x Genomics
- 10Health Catalyst
- 11AxogenNot disclosed
- 12Castle BiosciencesNot disclosed
- 13CerusNot disclosed
- 14Fulgent GeneticsNot disclosed
- 15Myriad GeneticsNot disclosed
- 16NeogenomicsNot disclosed
- 17Pacific Biosciences of CaliforniaNot disclosed
- 18Standard BioToolsNot disclosed
%20--%3e%3cdefs%3e%3cstyle%3e%20.st0%20{%20fill:%20%23fff;%20}%20%3c/style%3e%3c/defs%3e%3cg%20id='Layer_2'%3e%3cg%20id='Layer_1-2'%3e%3cpath%20class='st0'%20d='M41.2,129.5c-4-2-7.6-4.9-10.5-8.4-3.1-3.7-5.5-7.9-7.1-12.4-1.8-4.9-2.7-10-2.7-15.2,0-32,26.7-49.4,23.8-81.8,0-1.8-.3-3.6-.9-5.3-.5-1.6-1.4-3.1-2.5-4.3,4,2,7.6,4.9,10.5,8.4,3.1,3.7,5.5,7.9,7.1,12.4,1.7,4.9,2.6,10,2.7,15.2,0,27.7-25.3,48-25.3,77.7,0,2.6.4,5.2,1.3,7.6.9,2.2,2.2,4.2,3.6,6.1'/%3e%3cpath%20class='st0'%20d='M65.2,127.7c-2.7-1.4-5.1-3.3-7.1-5.6-2.1-2.5-3.7-5.3-4.8-8.4-1.2-3.3-1.8-6.7-1.8-10.2,0-21.5,19.7-33.7,16.6-61.4,3.8,3.4,7,9.5,8.8,14,1.2,3.3,1.8,6.7,1.8,10.2,0,18.5-16.9,32.1-16.9,52.1,0,1.7.3,3.5.9,5.1.5,1.6,1.4,3,2.5,4.2'/%3e%3cpath%20class='st0'%20d='M15.8,91.2c-2.7-1.4-5.1-3.3-7.1-5.6-2.1-2.5-3.7-5.3-4.8-8.4-1.2-3.3-1.8-6.7-1.8-10.2,0-21.5,19.7-33.7,16.6-61.4,3.8,3.4,7,9.5,8.8,14,1.2,3.3,1.8,6.7,1.8,10.2,0,18.5-16.9,32.1-16.9,52.1,0,1.7.3,3.5.9,5.1.5,1.6,1.4,3,2.5,4.2'/%3e%3cpath%20class='st0'%20d='M68.6,9.4c0,1.9-1.5,3.5-3.4,3.6s-3.5-1.5-3.6-3.4,1.5-3.5,3.4-3.6c0,0,0,0,0,0,1.9,0,3.4,1.4,3.5,3.3,0,0,0,0,0,0ZM62.5,9.4c0,1.4,1.1,2.7,2.5,2.7,0,0,0,0,0,0,1.4,0,2.6-1.1,2.6-2.6,0,0,0,0,0-.1,0-1.4-1.2-2.6-2.6-2.6s-2.6,1.2-2.6,2.6h0ZM64.6,11.2h-.8v-3.4c.4,0,.9-.1,1.3,0,.4,0,.8,0,1.2.2.2.2.3.5.3.7,0,.4-.3.7-.7.8h0c.3.1.6.5.6.8,0,.3.1.6.2.9h-.8c-.1-.3-.2-.5-.3-.8,0-.4-.3-.5-.7-.5h-.4v1.4ZM64.6,9.3h.4c.4,0,.8-.1.8-.5s-.2-.5-.7-.5c-.1,0-.3,0-.4,0v1Z'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.